These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

999 related articles for article (PubMed ID: 32310824)

  • 1. A novel immune-related genes prognosis biomarker for melanoma: associated with tumor microenvironment.
    Huang R; Mao M; Lu Y; Yu Q; Liao L
    Aging (Albany NY); 2020 Apr; 12(8):6966-6980. PubMed ID: 32310824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
    Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
    Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
    Han W; Huang B; Zhao XY; Shen GL
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.
    Qu Y; Zhang S; Zhang Y; Feng X; Wang F
    Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning-based identification of an immunotherapy-related signature to enhance outcomes and immunotherapy responses in melanoma.
    Deng Z; Liu J; Yu YV; Jin YN
    Front Immunol; 2024; 15():1451103. PubMed ID: 39355255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment.
    Liang XJ; Fu RY; Wang HN; Yang J; Yao N; Liu XD; Wang L
    J Immunol Res; 2021; 2021():5564568. PubMed ID: 34212052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a biomarker signature associated with anoikis to predict prognosis and immunotherapy response in melanoma.
    Wu Z; Zhang R; Bao J; Yin M; Wang X
    Arch Dermatol Res; 2024 May; 316(6):219. PubMed ID: 38787413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of tumor-infiltrating immune cells of melanoma with overall survival by immunogenomic analysis.
    Huang L; Chen H; Xu Y; Chen J; Liu Z; Xu Q
    Cancer Med; 2020 Nov; 9(22):8444-8456. PubMed ID: 32931642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genes associated with cellular senescence favor melanoma prognosis by stimulating immune responses in tumor microenvironment.
    Liang X; Lin X; Lin Z; Lin W; Peng Z; Wei S
    Comput Biol Med; 2023 May; 158():106850. PubMed ID: 37031510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.
    Lin J; Lin Y; Huang Z; Li X
    Comput Math Methods Med; 2020; 2020():8836493. PubMed ID: 33273963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel immune-related genes prognosis biomarker for hepatocellular carcinoma.
    Wang K; Chen X; Jin C; Mo J; Jiang H; Yi B; Chen X
    Aging (Albany NY); 2020 Nov; 13(1):675-693. PubMed ID: 33260154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of the immune cell infiltration-related gene signature in the prognosis of melanoma.
    Zeng Y; Zeng Y; Yin H; Chen F; Wang Q; Yu X; Zhou Y
    Aging (Albany NY); 2021 Jan; 13(3):3459-3482. PubMed ID: 33428606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prognostic model for melanoma patients on the basis of immune-related lncRNAs.
    Wang Y; Ba HJ; Wen XZ; Zhou M; Küçük C; Tamagnone L; Wei L; You H
    Aging (Albany NY); 2021 Mar; 13(5):6554-6564. PubMed ID: 33675585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic modeling of patients with metastatic melanoma based on tumor immune microenvironment characteristics.
    Liu J; Zhang X; Ye T; Dong Y; Zhang W; Wu F; Bo H; Shao H; Zhang R; Shen H
    Math Biosci Eng; 2022 Jan; 19(2):1448-1470. PubMed ID: 35135212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
    Liu X; Wang J
    Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
    Tian M; Yang J; Han J; He J; Liao W
    Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM.
    Rong D; Su Y; Jia D; Zeng Z; Yang Y; Wei D; Lu H; Cao Y
    Front Immunol; 2024; 15():1387316. PubMed ID: 38660305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of an immune infiltration landscape based on immune-related genes in cervical cancer.
    Yang Y; Wang N; Shi X; Wang Y; Yang C; Fan J; Jia X
    Comput Biol Med; 2022 Jul; 146():105638. PubMed ID: 35605489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma.
    Shen K; Wang Q; Wang L; Yang Y; Ren M; Li Y; Gao Z; Zheng S; Ding Y; Ji J; Wei C; Zhang T; Zhu Y; Feng J; Qin F; Yang Y; Wei C; Gu J
    Eur J Med Res; 2023 Sep; 28(1):352. PubMed ID: 37716991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.